Crestchem [CRSTCHM] vs Camlin Fine Sciences [CAMLINFINE] Detailed Stock Comparison
Crestchem
BSE
Loading...
Camlin Fine Sciences
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Crestchem wins in 11 metrics, Camlin Fine Sciences wins in 6 metrics, with 0 ties. Crestchem appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crestchem | Camlin Fine Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.46 | 51.69 | Crestchem |
| Price-to-Book Ratio | 5.46 | 3.95 | Camlin Fine Sciences |
| Debt-to-Equity Ratio | 0.00 | 77.88 | Crestchem |
| PEG Ratio | N/A | -0.71 | N/A |
| EV/EBITDA | 13.51 | 23.44 | Crestchem |
| Profit Margin (TTM) | 9.96% | -6.73% | Crestchem |
| Operating Margin (TTM) | 6.82% | -0.95% | Crestchem |
| EBITDA Margin (TTM) | 6.82% | N/A | N/A |
| Return on Equity | 36.47% | -15.89% | Crestchem |
| Return on Assets (TTM) | 25.86% | -6.87% | Crestchem |
| Free Cash Flow (TTM) | $15.21M | $-157.24M | Crestchem |
| Dividend Yield | 1.14% | N/A | N/A |
| 1-Year Return | -18.74% | 90.50% | Camlin Fine Sciences |
| Price-to-Sales Ratio (TTM) | 1.64 | 2.31 | Crestchem |
| Enterprise Value | $394.23M | $40.90B | Camlin Fine Sciences |
| EV/Revenue Ratio | 1.59 | 2.39 | Crestchem |
| Gross Profit Margin (TTM) | 21.36% | 44.07% | Camlin Fine Sciences |
| Revenue per Share (TTM) | $83 | $96 | Camlin Fine Sciences |
| Earnings per Share (Diluted) | $8.26 | $3.67 | Crestchem |
| Beta (Stock Volatility) | 0.49 | 0.33 | Camlin Fine Sciences |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Crestchem vs Camlin Fine Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crestchem | 1.87% | 1.60% | 11.90% | -19.22% | -30.09% | -53.63% |
| Camlin Fine Sciences | 2.10% | -7.72% | -9.41% | -36.63% | 13.09% | 39.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crestchem | -18.74% | -18.74% | -18.74% | -18.74% | -18.74% | -18.74% |
| Camlin Fine Sciences | 90.50% | 69.09% | 75.50% | 81.91% | 113.24% | 113.24% |
News Based Sentiment: Crestchem vs Camlin Fine Sciences
Crestchem
News based Sentiment: MIXED
September presented a mixed bag for Crestchem, with both positive price movements and significant declines. While long-term forecasts remain optimistic, the short-term volatility and fluctuating valuation metrics suggest a cautious approach is warranted. The continued insider buying and positive analyst outlook are encouraging, but the recent price swings require careful consideration.
Camlin Fine Sciences
News based Sentiment: POSITIVE
Camlin Fine Sciences is making a significant strategic move with the Vinpai acquisition, which is expected to expand its market reach. The stock has also shown positive momentum, indicating investor confidence. However, Vinpai's current financial performance and the P/E ratio fluctuations warrant continued monitoring.
Performance & Financial Health Analysis: Crestchem vs Camlin Fine Sciences
| Metric | CRSTCHM | CAMLINFINE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹409.05M | ₹40.45B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,107 | 572,357 |
| 90 Day Avg. Volume | 2,967 | 428,912 |
| Last Close | ₹136.35 | ₹194.37 |
| 52 Week Range | ₹114.00 - ₹329.00 | ₹95.59 - ₹333.30 |
| % from 52W High | -58.56% | -41.68% |
| All-Time High | ₹193.00 (Jun 16, 2025) | ₹333.30 (Jun 26, 2025) |
| % from All-Time High | -29.35% | -41.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | 0.07% |
| Quarterly Earnings Growth | -0.42% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | -0.07% |
| Operating Margin (TTM) | 0.07% | -0.01% |
| Return on Equity (TTM) | 0.36% | -0.16% |
| Debt to Equity (MRQ) | 0.00 | 77.88 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹24.92 | ₹47.98 |
| Cash per Share (MRQ) | ₹2.44 | ₹7.56 |
| Operating Cash Flow (TTM) | ₹17.84M | ₹-1,435,453,000 |
| Levered Free Cash Flow (TTM) | ₹27.26M | ₹-1,390,459,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.14% | N/A |
| Last 12-Month Dividend | ₹1.50 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Crestchem vs Camlin Fine Sciences
| Metric | CRSTCHM | CAMLINFINE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.46 | 51.69 |
| Forward P/E | N/A | 17.13 |
| PEG Ratio | N/A | -0.71 |
| Price to Sales (TTM) | 1.64 | 2.31 |
| Price to Book (MRQ) | 5.46 | 3.95 |
| Market Capitalization | ||
| Market Capitalization | ₹409.05M | ₹40.45B |
| Enterprise Value | ₹394.23M | ₹40.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.59 | 2.39 |
| Enterprise to EBITDA | 13.51 | 23.44 |
| Risk & Other Metrics | ||
| Beta | 0.49 | 0.33 |
| Book Value per Share (MRQ) | ₹24.92 | ₹47.98 |
Financial Statements Comparison: Crestchem vs Camlin Fine Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CRSTCHM | CAMLINFINE |
|---|---|---|
| Revenue/Sales | ₹50.31M | ₹4.24B |
| Cost of Goods Sold | ₹39.56M | ₹2.37B |
| Gross Profit | ₹10.75M | ₹1.87B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹3.43M | ₹21.09M |
| EBITDA | ₹4.88M | ₹275.58M |
| Pre-Tax Income | ₹4.70M | ₹-42.64M |
| Income Tax | ₹1.22M | ₹-100,000 |
| Net Income (Profit) | ₹3.48M | ₹-106.81M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CRSTCHM | CAMLINFINE |
|---|---|---|
| Cash & Equivalents | ₹7.32M | ₹1.04B |
| Total Current Assets | ₹43.06M | ₹11.83B |
| Total Current Liabilities | ₹29.97M | ₹8.46B |
| Long-Term Debt | N/A | ₹2.93B |
| Total Shareholders Equity | ₹74.76M | ₹8.75B |
| Retained Earnings | ₹44.76M | ₹996.35M |
| Property, Plant & Equipment | ₹309,625 | ₹35.37M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CRSTCHM | CAMLINFINE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CRSTCHM | CAMLINFINE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,107 | 572,357 |
| Average Daily Volume (90 Day) | 2,967 | 428,912 |
| Shares Outstanding | 3.00M | 187.92M |
| Float Shares | 1.98M | 82.57M |
| % Held by Insiders | 0.30% | 0.46% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Crestchem vs Camlin Fine Sciences
| Metric | CRSTCHM | CAMLINFINE |
|---|---|---|
| Last 12-Month Dividend | ₹1.50 | ₹0.00 |
| Last 12-Month Dividend Yield | 1.14% | N/A |
| 3-Year Avg Annual Dividend | ₹0.50 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.50% | N/A |
| 3-Year Total Dividends | ₹1.50 | ₹0.00 |
| Ex-Dividend Date | Aug 13, 2025 | N/A |